Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis.
about
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsPycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathwayEndothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences.Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?
P2860
Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@en
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@nl
type
label
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@en
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@nl
prefLabel
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@en
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@nl
P2860
P356
P1476
Interaction of carbamylated LD ...... sfunction and atherosclerosis.
@en
P2093
Alexei G Basnakian
Jawahar L Mehta
P2860
P304
P356
10.1093/EURHEARTJ/EHU122
P577
2014-04-02T00:00:00Z